1Sharp SC, Hellings JA. Efficacy and safety of selective serotonin reuptake inhibitors in the depression in children and adolescents[J]. Clin Drug Invest,2006,26(5) : 247-255.
2Dopheide JA. Recognizing and treating depression in children and adolescents [J]. Am J Health Syst Pharm,2006, 63(3) :233-243.
3Costelllo EJ, Foley D, Angold A. 10-Year research update review: the epidemiology of child and adolescent psychiatric disorders: Ⅱ Developmental epidemiology [J]. J Am Acad Child Adolesc Psychiatry, 2006,45(1): 8-25.
4Costello EJ, Mustillo S, Erkanli A,et al. Prevalence and development of psychiatric disorders in childhood and adolescence[J]. Arch Gen Psychiatry,2003,60(8):837-844.
5Brent DA, Birmaher B. Adolescent depression[J]. NEJM, 2002,347(9) : 667-671.
6Rushton JL, Forcier M, Schectman RM. Epidemiology of depressive symptoms in the National Longitudinal Study of Adolescent Health [J]. J Am Acad Child Adolesc Psychiatry,2002,41(2) : 199-205.
7Harrington R. Depressive disorders in children and adolescents: a review[M]//Maj M, Norman S (eds). Depressive disorders 2nd edn. West Sussex, UK: John Wiley &Sons Ltd, 2002:234-308.
8Timimi S. Rethinking childhood depression[J]. BMJ,2004,329(11):1394-1397.
9张明园.精神科评定量表手册[M].长沙:湖南科学技术出版社,2003.39.
10Hazell P, O'Connell D, Heathcote D, et al. Tricyclic drugs for depression in children and adolescents [M]//In the Cochrane Database of Systematic Reviews 2, Chichester, UK : John Wiley & Sons, Ltd,2005 : 1-10.
